| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/28/2010 | CN101279979B Separation and purification method of cefamandole nafate and preparation of cefathiamidine freeze-dried injectable powder |
| 07/28/2010 | CN101278950B Externally used ointment for curing empyrosis and method of producing the same |
| 07/28/2010 | CN101249108B Royal jelly acidic composition, preparation and uses thereof |
| 07/28/2010 | CN101249069B Tilmicosin long-acting injection and method of preparing the same |
| 07/28/2010 | CN101224262B Chinese traditional medicine compounds for treating asthenia of qi and blood type vasculitis and preparing method thereof |
| 07/28/2010 | CN101224253B Chinese traditional medicine compounds for treating diabetic foot and preparing method thereof |
| 07/28/2010 | CN101209334B Lung cancer-treating medicament and preparation thereof |
| 07/28/2010 | CN101199480B Compounded propofol fat emulsion injection containing analgesics and process for preparing same |
| 07/28/2010 | CN101190320B Traditional Chinese medicine granules for treating psoriasis |
| 07/28/2010 | CN101185650B Penciclovir ophthalmic temperature sensitivity in situ gel preparation and preparation method thereof |
| 07/28/2010 | CN101062285B Medicine for treating chronic gastritis, duodenitis and ulcer, and its preparation method |
| 07/28/2010 | CN101057861B Polycarbophil enteric coated medicinal composition |
| 07/27/2010 | US7764992 Method of esophageal function testing with a standardized thixotropic swallow challenge medium |
| 07/27/2010 | US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 07/27/2010 | US7763677 Water-dispersible resin composition and water-dispersible polyolefin resin composition |
| 07/27/2010 | US7763653 comprising the free bases of the local anesthetics prilocaine, lidocaine and bupivacaine in a weight ratio of 40-60%/25-45%/10-25%, respectively, the resulting mixture being a homogenous liquid having a melting point below 20 degrees C. |
| 07/27/2010 | US7763635 Uniform concentration in blood; oral administration for bladder dysfunction disorders |
| 07/27/2010 | US7763585 Methods for inhibiting tumor cell proliferation |
| 07/27/2010 | US7763583 Endoparasiticidal compositions for topical application |
| 07/27/2010 | US7763455 transdermal patches comprising flexible substrates, rigid pads and sample receiving surfaces configured for holding samples for in vivo or in vitro use |
| 07/27/2010 | US7763292 extracting a mixture of compounds from the black bean or their hulls with a polar solvent system; for treating breast, prostate, colon, hepatic cancer and leukemia; flavonols, flavones or isoflavones; anthocyanins |
| 07/27/2010 | US7763282 Quaternary compounds comprising propolis as the active substance |
| 07/27/2010 | US7763280 Tiotropium containing powder formulation for inhalation |
| 07/27/2010 | US7763278 As cholesterol lowering agents and for treatment of cardiovascular disorders |
| 07/27/2010 | US7763277 drug delivering phosphorous or a platinum anti-cancer substance through an implant comprising a resorbable mesoporous silicon carrier material; biodegradable; administering micronutrient, or trace elements or minerals |
| 07/27/2010 | US7763276 Chewable soft capsules having improved administration properties and process for producing the same |
| 07/27/2010 | US7763275 Nanocapsules having a polyelectrolyte envelope |
| 07/27/2010 | US7763274 Carrier matrix having open pores or capillary spaces serving as liquid reservoir; does not require uniform distribution |
| 07/27/2010 | US7763269 generating and delivering foam simultaneously using a syringe based device; comprises a sclerosant liquid, polidocanol solution, and gas N2, O2 or CO2; by inter alia causing a localised inflammatory reaction, favor the elimination of varicose veins and other disorders involving venous malformation |
| 07/27/2010 | US7763268 Load bearing hydrogel implants |
| 07/27/2010 | US7763265 UV barrier formulation for polyesters |
| 07/27/2010 | US7763252 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 07/27/2010 | US7763236 administering a formulation in the form of a toothpaste, mouthwash, mouth spray or chewing gum, comprising osteopontin effective to inhibit plaque bacterial growth on teeth enamel |
| 07/27/2010 | US7763235 has suspended therein flakes of a water hydratable film comprised of a homogeneous mixture of a water soluble hydroxyalkyl cellulose polymer and starch, the film matrix having entrained therein a therapeutic, cosmetic or decorative agent |
| 07/27/2010 | US7763014 Ingestible device |
| 07/27/2010 | CA2490826C Stable hydralazine pharmaceutical compositions |
| 07/27/2010 | CA2475025C Solid composition for oral or rectal administration having a melting point of 25.degree.c or higher and comprising a mixture of polar glycolipids and non-polar lipids |
| 07/27/2010 | CA2457034C Ophthalmic composition comprising an ascomycin |
| 07/27/2010 | CA2450539C Preservation of biological materials using fiber-forming techniques |
| 07/27/2010 | CA2448456C Solid pharmaceutical formulations comprising modafinil |
| 07/27/2010 | CA2435425C A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge |
| 07/27/2010 | CA2408915C Self-emulsifying active substance formulation and use of this formulation |
| 07/27/2010 | CA2384717C Topical treatment for prevention of ocular infections |
| 07/27/2010 | CA2373797C Methods of treating or preventing affective disorders |
| 07/22/2010 | WO2010083360A2 Controlled-release formulations |
| 07/22/2010 | WO2010083239A2 Therapeutic modulation of vaginal epithelium boundary lubrication |
| 07/22/2010 | WO2010083227A1 Consumable dissolving film comprising active ingredients derived from bacteria and fungi |
| 07/22/2010 | WO2010083183A1 Unit assembly for multiple film dosages, apparatus, and methods |
| 07/22/2010 | WO2010083129A2 Implantable delivery vehicle for ocular delivery of muscarinic antagonists |
| 07/22/2010 | WO2010083035A2 Transdermal administration of tamsulosin |
| 07/22/2010 | WO2010082910A1 Porous structures with modified biodegradation kinetics |
| 07/22/2010 | WO2010082863A1 Method and composition for treating multiple sclerosis (variants) |
| 07/22/2010 | WO2010082855A1 Pharmaceutical compositions comprising ziprasidone free base or ziprasidone hydrochloride and the method for their preparation |
| 07/22/2010 | WO2010082789A2 Anticancer compositions comprising cedrol in nanoparticle form |
| 07/22/2010 | WO2010082785A2 Oral pharmaceutical composition |
| 07/22/2010 | WO2010082602A1 Process for producing o/w microemulsion preparation for external application |
| 07/22/2010 | WO2010082487A1 Oil-gelling agent comprising reverse worm-like micelles and thickened gel-like composition |
| 07/22/2010 | WO2010082390A1 Low-concentration nutritional composition |
| 07/22/2010 | WO2010082220A2 Sustained release pharmaceutical composition of quetiapine and process for preparation thereof |
| 07/22/2010 | WO2010082219A2 An arteether injection for treatment of malaria |
| 07/22/2010 | WO2010082214A2 Fenofibrate formulation with enhanced oral bioavailability |
| 07/22/2010 | WO2010082149A1 Sprm pharmaceutical compositions methods of treatment using them |
| 07/22/2010 | WO2010082092A1 Propofol based anesthetic with preservative |
| 07/22/2010 | WO2010081984A1 Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules |
| 07/22/2010 | WO2010081824A2 Active coating of pharmaceutical dosage forms |
| 07/22/2010 | WO2010081815A1 Aqueous coacervate composition comprising poorly water-soluble biologically-active agents |
| 07/22/2010 | WO2010081800A2 New pharmaceutical compositions |
| 07/22/2010 | WO2010081781A1 Energetic nutritional composition comprising a laxative, electrolytes and carbohydrates |
| 07/22/2010 | WO2010081722A2 Orally disintegrating tablets for the treatment of pain |
| 07/22/2010 | WO2010081623A1 Pharmaceutical formulation of nanonised fenofibrate |
| 07/22/2010 | WO2010081485A1 Ointment for the topical treatment of haemorrhoids |
| 07/22/2010 | WO2010081286A1 Timing controlled – release porous tablet of diltiazem hydrochloride and the preparation method thereof |
| 07/22/2010 | WO2010081263A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof |
| 07/22/2010 | WO2010081262A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof |
| 07/22/2010 | WO2010081232A1 Honey product having a low water content |
| 07/22/2010 | WO2010062523A3 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| 07/22/2010 | WO2010062394A3 Implantable ocular drug delivery device and methods |
| 07/22/2010 | WO2010048028A3 Apparatus for preparing a sterile composition |
| 07/22/2010 | WO2010047765A3 Nanostructures for drug delivery |
| 07/22/2010 | WO2010045292A3 Nanoparticle compositions comprising liquid oil cores |
| 07/22/2010 | WO2010040055A3 Oral pharmaceutical formulations for antidiabetic compounds |
| 07/22/2010 | WO2010039007A3 Solid microstructure that enables multiple controlled release and method of manufacturing same |
| 07/22/2010 | WO2010039006A3 Method of manufacturing solid microstructure and solid microstructure manufactured based on same |
| 07/22/2010 | WO2010038241A3 Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid |
| 07/22/2010 | WO2010035273A3 Novel gastroretentive delivery system |
| 07/22/2010 | WO2010030667A3 Dosage forms for weakly ionizable compounds |
| 07/22/2010 | WO2010030201A3 Stable oral pharmaceutical composition containing a pharmaceutically acceptable salt of [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3r, 5s) - 3,5 dihydroxyhept-6- enoic acid |
| 07/22/2010 | WO2010021607A4 Pharmaceutical formulation |
| 07/22/2010 | WO2010009277A3 Immunogenic amphipathic peptide compositions |
| 07/22/2010 | WO2010006282A3 Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds |
| 07/22/2010 | WO2009137100A3 Proguanil to treat skin/mucosal diseases |
| 07/22/2010 | WO2009101110A3 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials |
| 07/22/2010 | WO2009076353A8 Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
| 07/22/2010 | US20100186102 Methods and compositions for post-transcriptional gene silencing |
| 07/22/2010 | US20100184953 Stable lipid-comprising drug delivery complexes and methods for their production |
| 07/22/2010 | US20100184823 dsRNA For Treating Viral Infection |
| 07/22/2010 | US20100184688 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/22/2010 | US20100183732 Novel one step process for preparing cross-linked poly(allylamine) polymers |
| 07/22/2010 | US20100183731 Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate |
| 07/22/2010 | US20100183730 High dose composition of ursodeoxycholic acid |